Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.62 |
| ▸ | LPL | P06858 | 11/20 | 0.62 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | P4HB | P07237 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | CCR8 | P51685 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29413172 | 1.00 | LIPG (0.62) | LIPGLPLDGAT1CYP1A2CYP2D6 | |
| SCHEMBL23624669 | 0.90 | LIPG (0.59) | LIPGLPLDGAT1P4HBCYP2A6 | |
| SCHEMBL21416108 | 0.90 | LIPG (0.51) | LIPGLPLDGAT1CYP1A2CYP2D6 | |
| SCHEMBL19106600 | 0.89 | LIPG (0.61) | LIPGLPLDGAT1P4HBCYP2A6 | |
| SCHEMBL19106491 | 0.88 | LIPG (0.51) | LIPGLPLDGAT1CYP1A2CYP2D6 | |
| SCHEMBL19106593 | 0.87 | LPL (0.54) | LIPGLPLDGAT1P4HBKDM4E | |
| SCHEMBL24475241 | 0.86 | LPL (0.50) | LIPGLPLDGAT1P4HBKDM4E | |
| SCHEMBL22222507 | 0.86 | LIPG (0.47) | LIPGLPLDGAT1CYP1A2CYP2D6 | |
| SCHEMBL19544227 | 0.86 | LPL (0.47) | LIPGLPLDGAT1CYP1A2CYP2D6 | |
| SCHEMBL23033871 | 0.86 | LIPG (0.56) | LIPGLPLDGAT1CYP1A2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3483153-B1 | COMPOUNDS COMPRISING TRIAZINE GROUP, FLUORENE-GROUP AND ARYL GROUP AND THEIR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20250101012-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2025-03-27 | — | — | US | disclosed |
| US-12139479-B2 | Heterocycle substituted pyridine derivative antifungal agents | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2024-11-12 | — | — | US | disclosed |
| EP-3529250-B1 | IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS | H LUNDBECK AS (DK) | 2023-12-06 | — | — | EP | disclosed |
| CN-116987124-A | Metal complexes as luminophores in organic electroluminescent devices | 默克专利有限公司 | 2023-11-03 | — | — | CN | disclosed |
| EP-3720438-B1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | AMPLYX PHARMACEUTICALS INC (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20230065881-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | AMPLYX PHARMACEUTICALS, INC. (US) | 2023-03-02 | — | — | US | disclosed |
| US-11512079-B2 | Heterocycle substituted pyridine derivative antifungal agents | AMPLYX PHARMACEUTICALS, INC. (US) | 2022-11-29 | — | — | US | disclosed |
| US-11322696-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2022-05-03 | — | — | US | disclosed |
| CN-109843884-B | Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitors | H.隆德贝克有限公司 | 2022-03-04 | — | — | CN | disclosed |
| WO-2011068204-A1 | BENZO[C]CARBAZOLE COMPOUND THAT HAS SUBSTITUENT BEARING PYRIDINE RING, AND ORGANIC ELECTROLUMINESCENT ELEMENT | JNC株式会社 (JP) | 2011-06-09 | — | — | WO | disclosed |
| EP-2315753-A2 | MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | Cheil Industries Inc. (KR) | 2011-05-04 | — | — | EP | disclosed |
| US-20100276673-A1 | Organic compound, and organic photoelectric device including the same | CHEIL INDUSTRIES, INC. (KR) | 2010-11-04 | — | — | US | disclosed |
| WO-2010074422-A1 | NOVEL COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2010-07-01 | — | — | WO | disclosed |
| US-20100127215-A1 | NOVEL ORGANOMETALLIC COMPLEXES WHICH EMIT IN THE RED TO GREEN SPECTRAL REGION AND THEIR USE IN OLEDS | BASF SE (DE) | 2010-05-27 | — | — | US | disclosed |
| US-20100109515-A1 | OLED WITH METAL COMPLEXES HAVING A HIGH QUANTUM EFFICIENCY | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2010-05-06 | — | — | US | disclosed |
| WO-2010024572-A2 | MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010024572-A2 | MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2010-03-04 | — | — | WO | disclosed |
| US-20090123720-A1 | SOLUTION PROCESSED ORGANOMETALLIC COMPLEXES AND THEIR USE IN ELECTROLUMINESCENT DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-05-14 | — | — | US | disclosed |
| US-20090123720-A1 | SOLUTION PROCESSED ORGANOMETALLIC COMPLEXES AND THEIR USE IN ELECTROLUMINESCENT DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101012-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | ERG28, DPM1, CYP51A1 | LIPG 4496/4885LPL 4735/4885DGAT1 4070/4885 |
| US-20230065881-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | ERG28, DPM1, CYP51A1 | LIPG 4496/4885LPL 4735/4885DGAT1 4070/4885 |
| US-12139479-B2 | Heterocycle substituted pyridine derivative antifungal agents | ERG28, DPM1, CYP51A1 | LIPG 4496/4885LPL 4735/4885DGAT1 4070/4885 |
| US-11512079-B2 | Heterocycle substituted pyridine derivative antifungal agents | ERG28, DPM1, CYP51A1 | LIPG 4496/4885LPL 4735/4885DGAT1 4070/4885 |
| US-20090123720-A1 | SOLUTION PROCESSED ORGANOMETALLIC COMPLEXES AND THEIR USE IN ELECTROLUMINESCENT DEVICES | BMI1, PCNA, DNMT1 | LIPG 4740/4885LPL 4439/4885DGAT1 4580/4885 |
| US-20100127215-A1 | NOVEL ORGANOMETALLIC COMPLEXES WHICH EMIT IN THE RED TO GREEN SPECTRAL REGION AND THEIR USE IN OLEDS | OCIAD1, ORC3, OCIAD2 | LIPG 2896/4885LPL 3087/4885DGAT1 600/4885 |
| US-20100276673-A1 | Organic compound, and organic photoelectric device including the same | OR10J3, EPB41, CACNA2D4 | LIPG 4642/4885LPL 3981/4885DGAT1 1679/4885 |
| US-11322696-B2 | Metal complexes | AP1M1, AP3M1, AP2M1 | LIPG 4256/4885LPL 4368/4885DGAT1 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.